,drug,MOAs
78,CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1,microtubule inhibitor
202,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,adrenergic receptor antagonist
162,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor
199,COCCn1c2c([n+](Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O,survivin inhibitor
216,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccc(N=C=S)cc2)CC1,opioid receptor agonist
14,Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,antiviral
106,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,bacterial cell wall synthesis inhibitor
206,CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)CN,cannabinoid receptor agonist
176,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,FGFR inhibitor|VEGFR inhibitor
160,Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1,thymidylate synthase inhibitor
77,CC(C=CC=C(C)/C=C/C1=C(C)CCCC1(C)C)=CC(=O)Nc1ccc(O)cc1,apoptosis stimulant|retinoid receptor agonist
145,O=C(Oc1cccc2cccnc12)c1ccccc1,antiinfective drug
234,CC1=CC(=O)c2ccccc2C1=O,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor
65,O=C(Nc1cccc2cccnc12)c1ccc(N2C(=O)[C@H]3[C@H]4C=C[C@H](C4)[C@H]3C2=O)cc1,PARP inhibitor
60,CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O,HCV inhibitor|XIAP inhibitor
64,CN(C)CCC=C1c2ccccc2CCc2ccccc21,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin√±norepinephrine reuptake inhibitor (SNRI)
35,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,CDK inhibitor
185,CC[C@@H](C(=O)C(C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)C1OC(CC)(C2CC[C@](O)(CC)[C@H](C)O2)C[C@@H]1C,bacterial permeability inducer
21,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1,histamine receptor antagonist
121,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor
88,O=C(Nc1cccnc1)N1CCC(Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,FAAH inhibitor
168,CN1N=C(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23,AKT inhibitor
126,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,NFkB pathway inhibitor|proteasome inhibitor
63,COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C,ATPase inhibitor|gastrin inhibitor
124,Nc1cc(N2CCCCC2)nc(N)[n+]1[O-],KATP activator|Kir6 channel (KATP) activator|vasodilator
90,CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1,enkephalinase inhibitor
111,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,fungal squalene epoxidase inhibitor
110,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12,prostanoid receptor antagonist
171,O=C(C=Cc1ccc(O)c(O)c1)OCCc1ccccc1,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor
137,CN1CCN2c3ncccc3Cc3ccccc3C2C1,adrenergic receptor antagonist|serotonin receptor antagonist
227,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor
6,O=C(C=Cc1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,niacinamide phosphoribosyltransferase inhibitor
22,Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,adenosine receptor antagonist
2,CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC,None
122,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,nedd activating enzyme inhibitor
177,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,RNA synthesis inhibitor|topoisomerase inhibitor
174,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
149,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21,mineralocorticoid receptor antagonist
161,Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1,purine antagonist
104,O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1,Aurora kinase inhibitor|JAK inhibitor
214,O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1,potassium channel blocker
228,O=C(O)COc1cccc(-c2ocnc2-c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1,IP1 prostacyclin receptor agonist
74,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC1NCCc2cc(OC)c(OC)cc21,protein synthesis inhibitor
45,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)c2ccccc2)C2(O)CC(OC(=O)C(O)C(NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C,tubulin polymerization inhibitor
217,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,carnitine palmitoyltransferase inhibitor
173,Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65,tyrosine kinase inhibitor
108,CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)c1cn(C)c2ccccc12,tachykinin antagonist
152,CNCCCC1c2ccccc2C=Cc2ccccc21,tricyclic antidepressant
93,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator
54,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO,endothelin receptor antagonist
118,CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12,norepinephrine reputake inhibitor|tricyclic antidepressant
48,Nc1nc2cc(Cl)ccc2o1,myorelaxant
96,Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,ribonucleotide reductase inhibitor
224,CCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C,ATP synthase inhibitor
51,Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,IGF-1 inhibitor
203,Nc1c2c(nc3ccccc13)CCCC2,acetylcholinesterase inhibitor
166,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,orexin receptor antagonist
172,CC(C)C[C@@H](C(=O)N[C@H](C(=O)OC1CCCC1)c1ccccc1)[C@H](O)C(=O)NO,peptidase inhibitor
47,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,prostanoid receptor agonist
73,Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1,PI3K inhibitor
136,Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1,smoothened receptor antagonist
91,CCCCCN=C(N)NN=Cc1c[nH]c2ccc(OC)cc12,serotonin receptor partial agonist
29,Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1,adenosine deaminase inhibitor|ribonucleotide reductase inhibitor
81,O=C1C(SCCO)=C(SCCO)C(=O)c2ccccc21,CDC inhibitor
82,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,glucosidase inhibitor
167,Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1,ubiquitin specific protease inhibitor
179,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,src inhibitor
209,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C,steroid
200,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,FLT3 inhibitor|JAK inhibitor
102,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor
170,Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,DNA methyltransferase inhibitor
163,CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1,calpain inhibitor
212,S=c1[nH]cnc2nc[nH]c12,immunosuppressant|protein synthesis inhibitor|purine antagonist
40,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,angiotensin receptor antagonist
97,COc1cc(C)c(C=CC(C)=CC=CC(C)=CC(=O)O)c(C)c1C,retinoid receptor agonist
157,COc1cc(C=CC(=O)CC(=O)C=Cc2ccc(O)c(OC)c2)ccc1O,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor
68,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,FLT3 inhibitor|KIT inhibitor|PKC inhibitor
32,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C1C,mTOR inhibitor
75,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,Aurora kinase inhibitor
130,C/C=C/C[C@@H](C)[C@@H](O)C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C)C(=O)N[C@H](C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(CC(C)C)C(=O)N(C)C(C(C)C)C(=O)N1C,calcineurin inhibitor
153,CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1,laxative
13,Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)N=Cc1cnc2ccc(Br)cn12,DNA protein kinase inhibitor|PI3K inhibitor
52,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1,selective serotonin reuptake inhibitor (SSRI)
230,CN(C)N=Nc1[nH]cnc1C(N)=O,DNA alkylating agent
155,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C,acetylcholine receptor agonist
56,C[C@@H]1CC[C@H]2[C@@H](C)C(OC(=O)CCC(=O)O)OC3O[C@]4(C)CC[C@@H]1[C@]32OO4,DNA synthesis inhibitor
105,CC(C)(C)c1ccc(C=CC(=O)Nc2ccc3c(c2)OCCO3)cc1,TRPV antagonist
182,OCc1ccc(-c2ccc(-c3ccc(CO)s3)o2)s1,MDM inhibitor
180,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,thyroid hormone stimulant
99,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,KIT inhibitor|VEGFR inhibitor
92,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2C1=NO,glycogen synthase kinase inhibitor|lipoxygenase inhibitor
85,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,cytochrome P450 inhibitor|SIRT activator
86,O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,DNA replication inhibitor|STAT inhibitor
46,Oc1c(Cl)cc(Cl)c2cccnc12,opioid receptor antagonist
113,CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC,ACAT inhibitor
151,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,apoptosis stimulant|NFkB pathway inhibitor
3,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,HIV protease inhibitor
98,OCCn1cc(-c2ccc3c(c2)CCC3=NO)c(-c2ccncc2)n1,RAF inhibitor
191,CCC1C=CC=CC[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C=CC(=O)OC2[C@@H](C)C(CC1)OC1(CC[C@@H](C)C(C[C@H](C)O)O1)[C@@H]2C,ATP synthase inhibitor|ATPase inhibitor
30,C=C[C@@]1(C)CC(=O)[C@@]2(O)[C@](C)(O1)[C@@H](OC(C)=O)[C@@H](O)[C@H]1C(C)(C)CC[C@H](O)[C@@]12C,adenylyl cyclase activator
